Back
Also listed as
SHTDY
OTC
Day Range
$2.68
$2.68
52-Week Range
$2.11
$2.70
Volume
200
50D / 200D Avg
$2.47
/
$2.37
Prev Close
$2.63
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 1.2 | 0.4 |
| P/B | 0.1 | 2.9 |
| ROE % | 9.2 | 3.7 |
| Net Margin % | 1.2 | 3.9 |
| Rev Growth 5Y % | 6.4 | 10.0 |
| D/E | 1.0 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
$2.44
$2.25 – $2.76
|
590 B | 1 |
| FY2026 |
$2.39
$2.20 – $2.70
|
580 B | 1 |
Key Takeaways
Revenue grew 6.38% annually over 5 years — modest growth
Earnings declined -22.14% over the past year
Generating 9.58B in free cash flow
P/E of 1.18 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 8.40%
Cash machine — converts 135.86% of earnings into free cash flow
Growth
Revenue Growth (5Y)
6.38%
Revenue (1Y)-2.02%
Earnings (1Y)-22.14%
FCF Growth (3Y)-28.14%
Quality
Return on Equity
9.19%
ROIC7.82%
Net Margin1.21%
Op. Margin2.77%
Safety
Debt / Equity
0.97
Current Ratio1.39
Interest Coverage5.92
Valuation
P/E Ratio
1.18
P/B Ratio0.11
EV/EBITDA1.88
Dividend Yield0.05%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -2.02% | Revenue Growth (3Y) | 2.89% |
| Earnings Growth (1Y) | -22.14% | Earnings Growth (3Y) | -9.07% |
| Revenue Growth (5Y) | 6.38% | Earnings Growth (5Y) | -0.48% |
| Profitability | |||
| Revenue (TTM) | 584.51B | Net Income (TTM) | 7.05B |
| ROE | 9.19% | ROA | 1.79% |
| Gross Margin | 7.57% | Operating Margin | 2.77% |
| Net Margin | 1.21% | Free Cash Flow (TTM) | 9.58B |
| ROIC | 7.82% | FCF Growth (3Y) | -28.14% |
| Safety | |||
| Debt / Equity | 0.97 | Current Ratio | 1.39 |
| Interest Coverage | 5.92 | Dividend Yield | 0.05% |
| Valuation | |||
| P/E Ratio | 1.18 | P/B Ratio | 0.11 |
| P/S Ratio | 0.01 | PEG Ratio | -0.36 |
| EV/EBITDA | 1.88 | Dividend Yield | 0.05% |
| Market Cap | 8.35B | Enterprise Value | 30.42B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 584.51B | 596.57B | 552.15B | 521.05B | 456.41B |
| Net Income | 7.05B | 9.05B | 8.53B | 7.76B | 7.19B |
| EPS (Diluted) | 2.26 | 2.90 | 2.73 | 2.49 | 2.31 |
| Gross Profit | 44.26B | 48.51B | 47.43B | 44.05B | 40.32B |
| Operating Income | 16.19B | 20.21B | 20.60B | 19.71B | 17.76B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 392.83B | 383.39B | 364.78B | 335.41B | 311.24B |
| Total Liabilities | 266.14B | 263.08B | 254.71B | 235.76B | 221.29B |
| Shareholders' Equity | 78.88B | 74.58B | 68.07B | 61.89B | 56.36B |
| Total Debt | 76.39B | 73.78B | 69.59B | 68.37B | 68.53B |
| Cash & Equivalents | 54.31B | 63.81B | 55.22B | 43.53B | 50.18B |
| Current Assets | 347.45B | 336.84B | 319.41B | 290.92B | 267.61B |
| Current Liabilities | 250.38B | 241.49B | 234.96B | 219.31B | 203.98B |